Published in

Taylor and Francis Group, Human Vaccines and Immunotherapeutics, p. 1-7, 2016

DOI: 10.1080/21645515.2016.1145847

Links

Tools

Export citation

Search in Google Scholar

Antibody response to respiratory syncytial virus infection in children <18 months old

Journal article published in 2016 by Susanna Esposito, Elisa Scarselli, Mara Lelii, Alessia Scala, Alessandra Vitelli, Stefania Capone, Marco Fornili, Elia Biganzoli, Annalisa Orenti ORCID, Alfredo Nicosia, Riccardo Cortese, Nicola Principi
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitated by knowledge of the natural immune response to this virus. The aims of this study were to evaluate the neutralizing antibody response of a cohort of healthy children